Trial Profile
The study of the rocuronium-sugammadex complex: particularly, study on safety to people with renal dysfunction about rocuronium-sugammadex complex
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Jan 2019
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 18 Jan 2019 Status changed from recruiting to completed.
- 17 Aug 2017 New trial record